LUCY HODGES: Open Payments
NPI 1639331994 · GREENWOOD, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$713 in 31 payments from 6 companies in 2025. Trend: 2023 $675 · 2024 $497 · 2025 $713
Food & beverage: $713
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $342 |
| Teva Pharmaceuticals USA, Inc. | 6 | $285 |
| Otsuka America Pharmaceutical, Inc. | 2 | $31 |
| Abbott Laboratories | 1 | $22 |
| E.R. Squibb & Sons, L.L.C. | 1 | $19 |
| Vanda Pharmaceuticals Inc. | 1 | $14 |
Products named: VRAYLAR, UZEDY, AUSTEDO XR, CARDIOMEMS, COBENFY, ABILIFY ASIMTUFII, FANAPT, ABILIFY MAINTENA.
Industry payments across MS — which companies pay providers there.
